Your account is not claimed yet. You can sign up with ORCID to claim your account.

Eva Altmann

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 6

Top Venues

Journal of medicinal chemistry

ChemMedChem

Angewandte Chemie (International ed. in English)

Biochemistry

Novartis Institutes for BioMedical Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Novartis Institutes for BioMedical Research

Switzerland

Associate Director, PhD :: Global Discovery Chemistry

Publications

Matthew Jones, Philipp Grosche, Andreas Floersheimer, Jérome André, Raphael Gattlen, Dieter Oser, Juliette Tinchant, Roman Wille, Barbara Chie-Leon, Marc Gerspacher, Peter Ertl, Nils Ostermann, Eva Altmann, Eusebio Manchado, Thomas Vorherr, Patrick Chène
Design and Biochemical Characterization of Peptidic Inhibitors of the Myb/p300 Interaction. Biochemistry (2023)
Edwige L Lorthiois, James Roache, David Barnes-Seeman, Eva Altmann, Ulrich Hassiepen, Gordon Turner, Rohit Duvadie, Viktor Hornak, Rajeshri G Karki, Nikolaus Schiering, Wilhelm A Weihofen, Francesca Perruccio, Amy Calhoun, Tanzina Fazal, Darija Dedic, Corinne Durand, Solene Dussauge, Kamal Fettis, Fabien Tritsch, Celine Dentel, Adelaide Druet, Donglei Liu, Louise Kirman, Julie Lachal, Kenji Namoto, Douglas Bevan, Rose Mo, Gabriela Monnet, Lionel Muller, Richard Zessis, Xueming Huang, Loren Lindsley, Treeve Currie, Yu-Hsin Chiu, Cary Fridrich, Peter Delgado, Shuangxi Wang, Micah Hollis-Symynkywicz, Joerg Berghausen, Eric Williams, Hong Liu, Guiqing Liang, Hyungchul Kim, Peter Hoffmann, Andreas Hein, Paul Ramage, Allan D'Arcy, Stefanie Harlfinger, Martin Renatus, Simon Ruedisser, David Feldman, Jason Elliott, Richard Sedrani, Juergen Maibaum, Christopher M Adams
Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach. Journal of medicinal chemistry 63 (15) (2020)
Carole Pissot Soldermann, Oliver Simic, Martin Renatus, Paulus Erbel, Samu Melkko, Markus Wartmann, Marc Bigaud, Andreas Weiss, Paul McSheehy, Ralf Endres, Paulo Santos, Jutta Blank, Ansgar Schuffenhauer, Guido Bold, Nicole Buschmann, Thomas Zoller, Eva Altmann, Paul W Manley, Ina Dix, Elisabeth Buchdunger, Julien Scesa, Jean Quancard, Achim Schlapbach, Frédéric Bornancin, Thomas Radimerski, Catherine H Régnier
Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing. Journal of medicinal chemistry 63 (23) (2020)
Peter Ertl, Eva Altmann, Jeffrey M McKenna
The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time. Journal of medicinal chemistry 63 (15) (2020)
Yesid A Ramirez, Thomas B Adler, Eva Altmann, Theresa Klemm, Christian Tiesmeyer, Florian Sauer, Stefan G Kathman, Alexander V Statsyuk, Christoph A Sotriffer, Caroline Kisker
Structural Basis of Substrate Recognition and Covalent Inhibition of Cdu1 from Chlamydia trachomatis. ChemMedChem 13 (19) (2018)
Eva Altmann, Paul Erbel, Martin Renatus, Michael Schaefer, Anita Schlierf, Adelaide Druet, Laurence Kieffer, Mickael Sorge, Keith Pfister, Ulrich Hassiepen, Matthew Jones, Simon Ruedisser, Daniela Ostermeier, Bruno Martoglio, Anne B Jefferson, Jean Quancard
Azaindoles as Zinc-Binding Small-Molecule Inhibitors of the JAMM Protease CSN5. Angewandte Chemie (International ed. in English) 56 (5) (2016)

Eva Altmann.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Eva Altmann